Physician profile
Mark Schusterman
NPI 1508800673
$2,809.26
in general payments reported to CMS, 2019-2025
18 companies · $220 in 2025
The $220 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $72.21 · 2020: $73.38 · 2021: $721 · 2022: $699 · 2023: $471 · 2024: $553 · 2025: $220.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,244.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,244.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $1,853.62 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 2 Breast Tissue Expander |
| Integra Lifesciences Corporation | $241.49 | 2021-2022 | |
| Galderma Laboratories, L.P. | $123.34 | 2019-2024 | |
| Sientra, INC. | $112.73 | 2022 | |
| Allergan, INC. | $81.10 | 2020-2021 | |
| Acera Surgical, INC. | $54.63 | 2024 | Restrata Wound Matrix |
| Axogen | $42.01 | 2022-2025 | |
| Tela Bio, INC. | $39.56 | 2021-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Ethicon US, LLC | $38.89 | 2023-2025 | Stratafix, Vistaseal |
| Musculoskeletal Transplant Foundation INC. | $37.79 | 2024 | |
| Abbvie INC. | $31.58 | 2023 | Botox |
| Smith+Nephew, INC. | $28.06 | 2023 | Pico 7 |
| Medtronic, INC. | $25.71 | 2024 | Ligasure |
| Merit Medical Systems INC | $20.89 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $20.63 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $20.35 | 2023 | Myrisk |
| Convatec INC. | $20.27 | 2024 | |
| Acelrx Pharmaceuticals, INC. | $16.61 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Schusterman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.